Previous Page  4 / 4
Information
Show Menu
Previous Page 4 / 4
Page Background

Volume 3

Journal of Neurology and Clinical Neuroscience

Neurology 2019 | Neuropsychology 2019 | Drug Delivery Summit 2019

June 24-25, 2019

Page 13

June 24-25, 2019 | Rome, Italy

Neurology and Healthcare

3

rd

WorldDrug Delivery and Formulations Summit

Clinical and Experimental Neuropsychology

4

th

International Conference on

International Conference on

&

Anna Voitiuk

Kharkiv Medical Academy of Postgraduate Education, Ukraine

Assessment of the quality of life of young men suffering from epilepsy

Introduction:

Epilepsyisoneofthemostfrequentandseriousneurologicaldiseases.Thisdiseasehasasignificantnegative

impact on all areas of the patient's functioning, reducing the quality of life. In everyday life, men with epilepsy regularly

experiencedifficulties.Basically,itisadecreaseinsocialandpersonalambitions,lowself-esteemcomparedtohealthypeople,

an increase in the level of anxiety and depression. Depression in peoplewith epilepsy is oftenmanifested by symptoms that

can be regarded as both side effects ofAEDs, and as manifestations of epilepsy per se (sleep disorders, changes in appetite,

behavioral disorders, inhibition or excessive excitability, etc.). The purpose of the study is to assess the Quality of Life

(QL) of youngmenwith epilepsy, to determine the leadingmechanisms of psychological protection and their effectiveness.

Methods:

The study included neuropsychological testing using the Quality of Life in Epilepsy-31 questionnaire

(Quality of life in epilepsy) and the Hamilton scale for assessing the severity of depression (HDRS).

Results:

Analysis of the test data of 40 patients (100%) showed that 6 (15%) of them rated their QL as "very low".

"Low" and "average" estimates of total QL were obtained from 10 (25%) and 16 (40%), respectively. In 8 (20%)

patients, the parameters were located in the intervals of "good" QL. No estimates of the "high" quality of life have

been received in any case. On the HDRS scale, the severity of depressive disorder was determined in 24 patients

(60%) as mild (7-17 points), moderate (18-24 points) - 14 patients (35%) and severe (>24 points) - 2 patients (5%).

Conclusion:

Thus, in patients with epilepsy revealed a significant decrease in QL, depending on the type of attack.

Estimates of the "high" quality of life have not been obtained. Depression and anxiety disorders greatly affect the quality

of life of patients, thus leading to an increase in the number of suicides.

Biography

Anna Voitiuk is an associate Professor at Kharkiv Medical Academy of Postgraduate Education, Department of Neurology and Child Neu-

rology, Kharkiv, Ukraine.

a_vojtyuk@yahoo.com

J Neurol Clin Neurosci, Volume 3